Global Vaccine Alliance Board Approves $3.5B Investment Strategy That Includes HPV Vaccine

Main Category: Cervical Cancer / HPV Vaccine
Article Date: 27 Jun 2008 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The board of the Global Alliance for Vaccines and Immunisation (GAVI) -- a public-private partnership that invests in childhood vaccinations in developing countries -- endorsed a $3.5 billion vaccine investment strategy for 2009 to 2020 that expands the focus to vaccines for adult women, including human papillomavirus, Reuters reports. According to Reuters, providing HPV vaccines to prevent cervical cancer and providing rubella vaccines to prevent miscarriages and birth defects were among the seven priority investments approved by the board.

GAVI -- backed by funders such as the Bill & Melinda Gates Foundation, as well as the governments of Brazil, France, Norway, South Africa and the United Kingdom -- also plans to prioritize vaccines to protect children against cholera, typhoid, rabies, meningitis A and Japanese encephalitis. "This strategy will attack some of the world's major killers and gives us a new challenge in our efforts to provide good health to the world's most vulnerable people," GAVI Executive Secretary Julian Lob-Levyt said in a statement.

In a report to the board, GAVI said, "The portfolio ... has the potential to avert approximately two million deaths across different age groups and all GAVI countries within 10 years." It added, "Moreover, with HPV and rubella vaccines, GAVI would have an opportunity to protect vulnerable women against a serious and fatal disease and congenital anomalies of their newborns" (MacInnis, Reuters, 6/25).

According to a GAVI release, over the next few months, the group will assess the remaining priority vaccines relative to country demand, as well as resource and vaccine availability. The board plans to meet later this year to decide on GAVI's financial commitment and implementation of the strategy (GAVI release, 6/25).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2008 The Advisory Board Company. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
National Partnership for Women & Families. "Global Vaccine Alliance Board Approves $3.5B Investment Strategy That Includes HPV Vaccine." Medical News Today. MediLexicon, Intl., 27 Jun. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/113026.php>

APA
National Partnership for Women & Families. (2008, June 27). "Global Vaccine Alliance Board Approves $3.5B Investment Strategy That Includes HPV Vaccine." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/113026.php.

Please note: If no author information is provided, the source is cited instead.


Cervical Cancer / HPV Vaccine

Most Popular Articles



Follow Our Cervical Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cervical Cancer / HPV Vaccine Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »